% | $
Quotes you view appear here for quick access.

Novavax, Inc. Message Board

  • medtrust2 medtrust2 May 3, 2014 2:36 PM Flag

    What matters about NVAX is the ability to rapidly produce ANY viral vaccine.

    No other company has recombinant nanoparticle technology that allows rapid production of a vaccine. Maybe NVAX never has to mass produce a vaccine candidate to fight an outbreak, but they have the capability and capacity to do. That's invaluable.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • NVAX only _collects_ on the value when it actually produces and sells a vaccine.

      Capability is nice IF you get a chance to apply it. They will.

      Sentiment: Strong Buy

    • Exactly.........NVAX may not have the size / scale geographically, but the VLP manufacturing process is the KEY differentiator......and again, it is a critical to understand.....its not just MERS, is whatever comes down the line, the VLP process creates a NEW approach to rapid vaccine development. These recent cases of MERS / H7N9 demonstrate this clearly......VLP will drive a change in how the FDA evaluates and approves vaccines. Big pharma knows this and will strike soon!

      Sentiment: Strong Buy

11.19+0.03(+0.27%)11:44 AMEDT